Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jun 13, 2024

BUY
$1.87 - $2.6 $20,216 - $28,108
10,811 New
10,811 $20,000
Q4 2022

Feb 01, 2023

SELL
$2.49 - $3.5 $29,805 - $41,895
-11,970 Reduced 2.13%
549,273 $1.4 Million
Q3 2022

Nov 10, 2022

BUY
$2.82 - $3.58 $45,072 - $57,219
15,983 Added 2.93%
561,243 $1.64 Million
Q2 2022

Aug 11, 2022

SELL
$2.59 - $3.92 $26,034 - $39,403
-10,052 Reduced 1.81%
545,260 $1.7 Million
Q1 2022

May 12, 2022

SELL
$3.0 - $4.25 $15,030 - $21,292
-5,010 Reduced 0.89%
555,312 $2.24 Million
Q4 2021

Feb 11, 2022

BUY
$3.85 - $6.71 $53,172 - $92,671
13,811 Added 2.53%
560,322 $2.26 Million
Q3 2021

Nov 12, 2021

BUY
$5.6 - $8.58 $124,538 - $190,810
22,239 Added 4.24%
546,511 $3.09 Million
Q2 2021

Aug 12, 2021

BUY
$7.16 - $9.41 $3.75 Million - $4.93 Million
524,272 New
524,272 $4.56 Million

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $760M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.